Tengfei Li

Dr. Tengfei Li

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2026 in Cancers
Verified
Journal Article
Open access
PDF file
TLTengfei Li
Tengfei Li
CXChengyuan Xu
Chengyuan Xu
YGYang Guo
Yang Guo
YXYanYan Xu
YanYan Xu
KCKaiji Chen
Kaiji Chen
MLMoubin Lin
Moubin Lin
Background: Midkine (MDK), a secreted heparin-binding growth factor, is involved in tumor progression and metastasis. While serum MDK is widely recognized as a potential prognostic biomarker for colorectal cancer (CRC), its specific functional role and underlying mechanisms in CRC development are not fully understood. Methods: The four publicly available CRC microarray datasets—GSE41258, GSE44076, GSE81558, and GSE117606—along with TCGA-COAD and TCGA-READ datasets and their associated clinical data were obtained. MDK expression was measured at both the mRNA and protein levels using quantitative real-time PCR (qRT-PCR) and Western blotting. To investigate its oncogenic functions, a comprehensive set of assays was performed: transwell and wound healing assays for invasion and migration; CCK-8 and colony formation assays for proliferation; and tail vein/spleen injection models combined with xenograft models to study metastasis and tumor growth in vivo. To uncover underlying mechanisms, Western blotting was used to examine the involvement of epithelial–mesenchymal transition (EMT) and the PI3K/AKT signaling pathway. Results: MDK is significantly overexpressed in CRC tissues and cells compared to normal tissues and cells. Notably, patients with high MDK levels show poorer overall survival (OS). Overexpression of MDK increases CRC invasion, migration, proliferation, and metastasis both in vivo and in vitro, while its knockdown reverses these effects. Mechanistically, MDK activates the PI3K/AKT pathway, leading to increased AP2A1 expression and promotion of EMT in CRC. Conclusions: MDK promotes invasion, migration, proliferation, metastasis, and EMT in CRC cells through the PI3K/AKT pathway by inducing AP2A1 expression, which could serve as a diagnostic marker. The PI3K inhibitor LY294002 significantly reduces AP2A1 levels and inhibits MDK-induced malignant behaviors. Targeting MDK-related signaling pathways may offer new strategies for CRC treatment.

13 September 2022 in Research Square
Verified
Preprint
Open access
PDF file
JZJianming Zhang
Jianming Zhang
YYYan Yang
Yan Yang
ZLZuyin Li
Zuyin Li
QDQi Ding
Qi Ding
JSJiahong Song
Jiahong Song
TLTengfei Li
Tengfei Li
Background: There is extensive genetic and transcriptional heterogeneity in Gastric cancer (GC). Increasing evidence has demonstrated that cuproptosis could exert an important function in tumor progression. Long noncoding RNAs (lncRNAs),which exert a pivotal function in the development of GC, especially involving in tumor-associated immune progression. Thus, it is indispensable to establish a cuproptosis-related lncRNAs (crlncRNAs)signature. Methods: Based on 19 genes associated with cuproptosis, to investigate whether lncRNA was markedly associated with cuproptosis, Pearson correlation analysis came in handy. To identify characteristics of copper death-related lncRNAs and build predictive models, univariate Cox regression and least absolute shrinkage and selection operator (LASSO) analysis were used to identify 6 key cuproptosis-related lncRNAs (crlncRNAs). To validate the predictive power of the signature, Cox regression on the univariate and multivariate data, Kaplan-Meier survival analysis, receiver operating characteristic curves (ROC), area under the curve (AUC) are used in the training, testing, and total sets. We further examined the functional enrichment, the status of immune cells, immune cell infiltrations, landscape of mutation status, Tumor Immune Dysfunction and Exclusion (TIDE) score, correlation and drugs sensitivity among the different risk groups. Results: 16 prognostically related crlncRNAs(PRcrlncRNAs) were filtered to make the prognostic signature, 6 key crlncRNAs were included. The risk score was the independent parameter in predicting OS (Overall survival) according to Cox regression on the univariate and multivariate data and it is acceptable in predicting prognosis concerning the accuracy of the model, which is confirmed by ROC analysis in GC patients. Differences in median OS and PFS (progression-free survival) between high- and low-risk groups were statistically significant. The TIDE score was higher in high-risk patients, which could predict less chemosensitivity with some drugs in the light of the TIDE analysis. Conclusions: Our study is innovative to develop and validate a novel STAD-associated crlncRNAs model that could effectively instruct the prognosis, as well as participating in the immune microenvironment in STAD, which would provide a new insight in the development of molecularly targeted therapies associated to cuproptosis.